• About Us
    • Company
    • Chairman's Message
    • Team Profile
    • Our History
    • Corporate Culture
    • Corporate Honors
  • Technology
    • Research and Development
    • Innovation Platform
    • Innovative Drugs
    • Research and Development Pipeline
  • Products
    • Digestive System
    • Cardiovascular System
    • Endocrine System
    • Nervous System
    • Inflammation
    • Respiratory System
  • News
    • Company News
    • Media Coverage
  • Investor Relations
    • Announcements and Circulars
    • Financial Reports
    • Prospectus
    • Corporate Governance
    • Contact IR
  • Careers
    • Talent Development
    • Recruitment Position
  • Contact Us
    • Contact Us
    • Product Consultation
  • 简 繁 En
  • 中文
  • 繁体
  • EN
  • About Us
  • Company
  • Chairman's Message
  • Team Profile
  • Our History
  • Corporate Culture
  • Corporate Honors
  • Technology
  • Research and Development
  • Innovation Platform
  • Innovative Drugs
  • Research and Development Pipeline
  • Products
  • Digestive System
  • Cardiovascular System
  • Endocrine System
  • Nervous System
  • Inflammation
  • Respiratory System
  • News
  • Company News
  • Media Coverage
  • Investor Relations
  • Announcements and Circulars
  • Financial Reports
  • Prospectus
  • Corporate Governance
  • Contact IR
  • Careers
  • Talent Development
  • Recruitment Position
  • Contact Us
  • Contact Us
  • Product Consultation
Company News

publish time: 2026-03-09

返回
About Us
Technology
Products
News
Investor Relations
Careers
Contact Us

Fujian Haixi Pharmaceutical Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min)-Non-operating-2023-0063

Some texts and images on this website are sourced from the Internet for sharing and learning purposes only. If any content infringes your rights and interests, please notify us promptly, and we will handle or remove the relevant materials without delay.